In our last post we described various treatments for basal cell carcinomas (BCCs)—the most common form of skin cancer in the nation—including Mohs Micrographic Surgery. This advanced technique has an exceptionally high cure rate while removing as little healthy tissue as possible, typically providing the best possible aesthetic and functional outcome. Our experienced dermatologist, Dr. Adam J. Mamelak, often recommends Mohs Micrographic Surgery for qualified patients due to the broad array of benefits this leading method offers.
BCCs are most commonly located on the face, head, and neck, including the eyelids, lips, nose, and ears. These sensitive areas require highly accurate treatment to preserve the appearance and functionality of the features. More than merely a cosmetic issue, damage to the eyelids, for instance, can impair vision. Dr. Mamelak prioritizes maintaining the anatomic function of particular features when performing Mohs Surgery, which utilizes a precision tissue sparing method. During the procedure, he creates a map of the BCCs and removes a single layer of tissue at a time until the cancer has been eliminated, as determined through repeated microscopic checks. Success rates with Mohs Surgery are dramatic, typically reaching over 99 percent. As a result, the BCC is unlikely to return to the treated area.
Mohs Micrographic Surgery is not appropriate for every individual. This technique is most commonly used for BCCs and squamous cell carcinomas (SCCs). Additionally, Mohs Surgery may be recommended for patients with suppressed immune systems and/or certain genetic disorders, as well as people who have previously undergone radiation therapy. Dr. Mamelak will determine candidacy requirements during the initial consultation.
For more information about Mohs Micrographic Surgery, or if you wish to schedule a consultation with Dr. Mamelak, please contact our office today.